ArticleJournal of pharmacokinetics and pharmacodynamics2025

Application of model-informed drug development (MIDD) for dose selection in regulatory submissions for drug approval in Japan.

JPMA MIDD Task force et al.PubMed ↗Publisher ↗

No numbers read from the abstract.